These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 26183670)
21. Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience. Wheler J; Tsimberidou AM; Moulder S; Cristofanilli M; Hong D; Naing A; Pathak R; Liu S; Feng L; Kurzrock R Clin Breast Cancer; 2010 Feb; 10(1):46-51. PubMed ID: 20133258 [TBL] [Abstract][Full Text] [Related]
22. [Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]. Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A Bull Cancer; 2017 Apr; 104(4):332-343. PubMed ID: 28214007 [TBL] [Abstract][Full Text] [Related]
23. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647 [TBL] [Abstract][Full Text] [Related]
24. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients. Martino M; Bottini A; Rosti G; Generali D; Secondino S; Barni S; Maisano R; Lanza F; Castagna L; Pedrazzoli P Expert Opin Biol Ther; 2012 Nov; 12(11):1505-15. PubMed ID: 22946512 [TBL] [Abstract][Full Text] [Related]
25. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow. Brockstein BE; Williams SF Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954 [TBL] [Abstract][Full Text] [Related]
26. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle. Bashey A; Corringham S; Garrett J; Lane TA; Gilpin EA; Corringham RE; Law P; Ho AD Bone Marrow Transplant; 2000 Mar; 25(5):519-24. PubMed ID: 10713629 [TBL] [Abstract][Full Text] [Related]
27. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Demirer T; Uysal VA; Ayli M; Genc Y; Ilhan O; Koc H; Dagli M; Arat M; Gunel N; Fen T; Dincer S; Ustael N; Yildiz M; Ustun T; Seyrek E; Ozet G; Muftuoglu O; Akan H Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881 [TBL] [Abstract][Full Text] [Related]
28. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. Kim YS; Konoplev SN; Montemurro F; Hoy E; Smith TL; Rondón G; Champlin RE; Sahin AA; Ueno NT Clin Cancer Res; 2001 Dec; 7(12):4008-12. PubMed ID: 11751494 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry. Pedrazzoli P; Martinelli G; Gianni AM; Da Prada GA; Ballestrero A; Rosti G; Frassineti GL; Aieta M; Secondino S; Cinieri S; Fedele R; Bengala C; Bregni M; Grasso D; De Giorgi U; Lanza F; Castagna L; Bruno B; Martino M; Biol Blood Marrow Transplant; 2014 Apr; 20(4):501-6. PubMed ID: 24374214 [TBL] [Abstract][Full Text] [Related]
30. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer. Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752 [TBL] [Abstract][Full Text] [Related]
31. Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. Nieto Y; Cagnoni PJ; Shpall EJ; Matthes S; Barón A; Jones RB; Bearman SI Clin Cancer Res; 1999 Jul; 5(7):1731-7. PubMed ID: 10430076 [TBL] [Abstract][Full Text] [Related]
32. Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection. Montemurro F; Rondón G; Munsell M; Smith TL; Donato ML; Gajewski JL; Rahman ZU; Buzdar AU; Champlin RE; Ueno NT Biol Blood Marrow Transplant; 2003 May; 9(5):330-40. PubMed ID: 12766883 [TBL] [Abstract][Full Text] [Related]
33. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer. Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174 [TBL] [Abstract][Full Text] [Related]
34. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma]. Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324 [TBL] [Abstract][Full Text] [Related]
35. Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer. Kamal AH; Camacho F; Anderson R; Wei W; Balkrishnan R; Kimmick G Breast Cancer Res Treat; 2012 Jul; 134(1):371-8. PubMed ID: 22460617 [TBL] [Abstract][Full Text] [Related]
36. Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support. Hensel M; Schneeweiss A; Sinn HP; Egerer G; Kornacker M; Solomayer E; Haas R; Bastert G; Ho AD Stem Cells; 2002; 20(1):32-40. PubMed ID: 11796920 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation. Kaloyannidis P; Voutiadou G; Baltadakis I; Tsirigotis P; Spyridonidis A; Repousis P; Balta A; Tsimberis S; Karakasis D; Sakellari I; Dervenoulas I; Harhalakis N; Anagnostopoulos A Biol Blood Marrow Transplant; 2012 Mar; 18(3):451-7. PubMed ID: 21803018 [TBL] [Abstract][Full Text] [Related]
38. [High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma]. Kier P; Ruckser R; Buxhofer V; Habertheuer KH; Zelenka P; Tatzreiter G; Hübl G; Kittl E; Hauser A; Sebesta C; Hinterberger W Acta Med Austriaca Suppl; 2000; 52():33-6. PubMed ID: 11261276 [TBL] [Abstract][Full Text] [Related]
39. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. Rizzo JD; Williams S; Wu JT; Pecora AL; Lazarus HM; Bolwell B; Fields KK; Gale RP; Elfenbein G; Horowitz MM; Antman KH Bone Marrow Transplant; 2003 Jul; 32(2):151-5. PubMed ID: 12838279 [TBL] [Abstract][Full Text] [Related]
40. Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Boudin L; Gonçalves A; Sabatier R; Moretta J; Sfumato P; Asseeva P; Livon D; Bertucci F; Extra JM; Tarpin C; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Sobol H; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Viens P; Eisinger F; Chabannon C Bone Marrow Transplant; 2016 Aug; 51(8):1082-6. PubMed ID: 27042835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]